EPISODE · Feb 1, 2022 · 14 MIN
BRAIN Biotech AG Financial Results FY 2020 / 21 | Innovations, and Sustainability Commitments with IR
from Investor Insights from CEOs & CFOs | seat11a · host seat11a.com
BRAIN Biotech AG FY 2020/21: Key Takeaways Journey Towards a Sustainable FutureIn this in-depth video presentation, Michael Schneiders, Investor Relations, discusses BRAIN Biotech AG’s financial highlights from FY 2021, its two-pillar business model, and commitment to the United Nations’ Sustainable Development Goals. Innovative Projects and Patent DevelopmentsLearn about BRAIN’s groundbreaking incubator projects, such as Perillic Active and Metagenome Cas 01, and the latest developments in their BEC patent. Navigating Challenges and Ensuring GrowthDiscover how BRAIN Biotech AG managed the challenges posed by COVID-19 and maintained a strong long-term revenue growth trajectory. The presentation also covers analyst coverage and insights into the company’s strategic direction. Comprehensive Overview of a Leading Biotechnology CompanyDon’t miss this detailed look at BRAIN Biotech AG, a leading European industrial biotechnology company, and its role in driving innovation and sustainability. Other videos: Elevator Pitch Company Presentation Deep Dive Presentation Financial Results Presentation ESG Presentation T&C: This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.
Embed this episode
Ready to play
BRAIN Biotech AG Financial Results FY 2020 / 21 | Innovations, and Sustainability Commitments with IR
No transcript for this episode yet
Similar Episodes
No similar episodes found.